Page last updated: 2024-08-16

ribavirin and Liver Failure

ribavirin has been researched along with Liver Failure in 44 studies

Research

Studies (44)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (6.82)	18.2507
2000's	16 (36.36)	29.6817
2010's	21 (47.73)	24.3611
2020's	4 (9.09)	2.80

Authors

Authors	Studies
Boettler, T; Emmerich, F; Fischer, N; Gundlach, S; Hofmann, M; Huang, J; Huzly, D; Kemming, J; Llewellyn-Lacey, S; Lütgehetmann, M; Neumann-Haefelin, C; Panning, M; Pischke, S; Price, DA; Schulze Zur Wiesch, J; Tanriver, Y; Thimme, R; Warnatz, K	1
Hui, W; Wei, L	1
Burmeister, T; Hofmann, J; Ingwersen, V; Keller, U; Le Coutre, P; Leng, C; Maschmeyer, G; Muche, M; Schneider, T; Schwartz, S	1
Liu, HY; Zhao, JM	1
Cui, LY; Liu, LD; Nan, YM; Zhao, W	1
Chu, CJ; Hou, MC; Huang, YH; Wu, SH	1
Aldámiz-Echevarría, T; Bellón, JM; Berenguer, J; Carrero, A; Díez, C; Fanciulli, C; Garcia-Broncano, P; Jiménez-Sousa, MA; Medrano, LM; Miralles, P; Pérez-Latorre, L; Resino, S	1
de los Santos-Gil, I; Gea, I; Girón-González, JA; López-Cortés, LF; Macías, J; Márquez, M; Merchante, N; Merino, D; Mira, JA; Pineda, JA; Ríos-Villegas, MJ; Rivero, A; Rivero-Juárez, A; Téllez, F; Torres-Cornejo, A	1
Baumann, U; Goldschmidt, I; Junge, N; Manns, M; Pfister, ED; Pischke, S; Wedemeyer, H	1
Aqel, BA; Charlton, MR; Henry, TM; Keaveny, AP; Koning, L; Murphy, JL; Pungpapong, S; Rosser, BG; Ryland, KL; Satyanarayana, R; Vargas, HE; Yataco, ML	1
Hsu, SH; Wang, SN; Yeh, ML	1
Rakela, J; Unzueta, A	1
Chiba, T; Fujimoto, Y; Haga, H; Ito, T; Kaido, T; Marusawa, H; Miyagawa-Hayashino, A; Mori, A; Ogawa, K; Ueda, Y; Uemoto, S; Yoshizawa, A	1
Bertuzzo, VR; Calderaro, A; Morelli, MC; Pinna, AD; Ravaioli, M; Viale, P	1
Denk, G; Eberle, J; Guba, M; Kaspar, M; Kolligs, F; Pichler, M; Seybold, U; Spannagl, M; Stemberger, M	1
Gerlei, Z; Gervain, J; Horváth, G; Hunyady, B; Lengyel, G; Makara, M; Pár, A; Rókusz, L; Szalay, F; Telegdy, L; Tornai, I; Werling, K	1
Abraldes, JG; Albillos, A; Bañares, R; Bosch, J; Calleja, JL; Forns, X; García-Pagán, JC; García-Retortillo, M; Lens, S; Rincón, D; Sanchez-Tapias, JM	1
Kattakuzhy, S; Kottilil, S; Tang, L; Ward, H; Wilson, E	1
Agarwal, R; Ahmad, J; Bach, N; Bansal, M; Bichoupan, K; Branch, A; Chang, C; Dieterich, D; Friedman, S; Gardenier, D; Grewal, P; Harty, A; Im, G; Khaitova, V; Kim-Schluger, L; Ku, L; Leong, J; Liu, L; Motamed, D; Ng, M; Odin, J; Patel, N; Perumalswami, P; Schiano, T; Yalamanchili, R	1
Durlik, M; Hreńczuk, M; Kosieradzki, M; Małkowski, P; Pacholczyk, M; Sowińska, R; Tronina, O	1
Berg, T; Ferenci, P; Gschwantler, M; Herzer, K; Jimenez-Exposito, MJ; Peck-Radosavljevic, M; Petersen, J; Rockstroh, J; Spengler, U; van der Valk, M; Wedemeyer, H; Weiland, O; Welzel, TM; Zeuzem, S; Zhao, Y	1
Bonkovsky, HL; Di Bisceglie, AM; Dienstag, JL; Everson, GT; Ghany, MG; Hoefs, JC; Lee, WM; Lindsay, KL; Lok, AS; Morishima, C; Naishadham, D; Shiffman, ML; Wright, EC	1
Adeyi, O; Girgrah, N; Herath, C; Kashfi, A; Levy, GA; Lilly, L; Renner, EL; Selzner, M; Selzner, N; Therapondos, G	1
Bahra, M; Berg, T; Biermer, M; Boas-Knoop, S; Eurich, D; Neuhaus, P; Neuhaus, R; Neumann, U	1
Kandel, C; Kandel, G	1
Appelman, H; Bifano, M; Dimitrova, D; Fontana, RJ; Hindes, R; Hughes, EA	1
Bessede, T; Buffet, C; Charpentier, B; Durrbach, A; Hassan, Q; Roche, B; Samuel, D	1
García-Samaniego, J; González-Lahoz, J; Núñez, M; Pérez-Olmeda, M; Ríos, P; Soriano, V	1
Cupelli, L; DePamphilis, J; Dieterich, D; Duff, F; Larrey, D; Mauss, S; Passe, S; Solsky, J; Torriani, FJ; Valenti, W	1
delaGarza, J; Madariaga, J; Neff, GW; Nishida, S; O'Brien, CB; Ruiz, P; Safdar, K; Schiff, E; Shire, N	1
Simon, K; Szymczak, A	1
Jankowska, I; Pawłowska, J; Rokitka, M; Socha, J; Sokal, E; Teisseyre, M	1
Bani-Sadr, F; Bonarek, M; Cacoub, P; Carrat, F; Colin de Verdiere, N; Lunel-Fabiani, F; Morand, P; Perronne, C; Pialoux, G; Piroth, L; Pol, S; Rosenthal, E	1
Arakawa, Y; Moriyama, M	1
Franchini, M	1
Cacayorin, E; Cedron, H; Kato, T; Levi, D; Moon, J; Nishida, S; Pyrsopoulos, N; Schiff, E; Selvaggi, G; Taffaro, M; Tzakis, A; Weppler, D	1
Hansen, BE; Heathcote, EJ; Hofmann, WP; Janssen, HL; Manns, MP; Reichen, J; Schalm, SW; Veldt, BJ; Wedemeyer, H; Zeuzem, S	1
Aucejo, F; Hanouneh, IA; Lopez, R; Miller, C; Quinn, MK; Zein, NN	1
Belghiti, J; Benhamou, JP; Bernuau, J; Degott, C; Durand, F; Erlinger, S; Marcellin, P; Molas, G; Sauvanet, A; Sicot, C	1
Koretz, RL	1
Lawrence, SP	1
Berenguer, M; Wright, TL	1
Braun, F; Ramadori, G; Ringe, B; Wietzke, P	1

Reviews

9 review(s) available for ribavirin and Liver Failure

Article	Year
New insights in recurrent HCV infection after liver transplantation. Clinical & developmental immunology, 2013, Volume: 2013 Topics: Antibodies, Neutralizing; Antiviral Agents; Glucocorticoids; Hepacivirus; Hepatitis C, Chronic; Hepatocytes; Humans; Immunosuppressive Agents; Interferon-alpha; Liver Failure; Liver Transplantation; Polyethylene Glycols; Recombinant Proteins; Recurrence; Ribavirin; Risk Factors; Viral Envelope Proteins; Virus Internalization	2013
Hepatitis E infection in liver transplant recipients. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2014, Volume: 20, Issue:1 Topics: Animals; Chronic Disease; Disease Progression; Feces; Fibrosis; Food Microbiology; Hepatitis E; Humans; Immunosuppression Therapy; Interferons; Liver; Liver Failure; Liver Transplantation; Ribavirin; RNA, Viral	2014
[Hepatitis C: diagnosis, anti-viral therapy, after-care. Hungarian consensus guideline]. Orvosi hetilap, 2015, Mar-01, Volume: 156, Issue:9 Topics: Antiviral Agents; Consensus; Disease Progression; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Hepatitis C; Humans; Hungary; Insurance Coverage; Insurance, Health; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Liver Failure; Liver Neoplasms; Oligopeptides; Polyethylene Glycols; Proline; Protease Inhibitors; Recombinant Proteins; Registries; Ribavirin; Treatment Outcome	2015
Dual sofosbuvir and ribavirin therapy for chronic hepatitis C infection. Expert review of gastroenterology & hepatology, 2016, Volume: 10, Issue:1 Topics: Antiviral Agents; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Drug Resistance, Viral; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Liver Failure; Liver Transplantation; Recurrence; Renal Insufficiency; Ribavirin; Sofosbuvir	2016
[Molecular virology and treatment of patients with chronic hepatitis C]. Przeglad epidemiologiczny, 2005, Volume: 59, Issue:2 Topics: Aged; Antiviral Agents; Carcinoma, Hepatocellular; Drug Carriers; Drug Therapy, Combination; Female; Fibrosis; Hepatitis C Antibodies; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Failure; Liver Neoplasms; Male; Middle Aged; Poland; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Time Factors; Treatment Outcome	2005
Treatment of interferon-alpha for chronic hepatitis C. Expert opinion on pharmacotherapy, 2006, Volume: 7, Issue:9 Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Liver Failure; Liver Neoplasms; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin	2006
Is time to treat for HCV all the HIV/HCV co-infected hemophiliacs? Hematology (Amsterdam, Netherlands), 2006, Volume: 11, Issue:3 Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antiviral Agents; Carcinoma, Hepatocellular; Case Management; Clinical Trials as Topic; Cohort Studies; Disease Progression; Drug Therapy, Combination; Hemophilia A; Hepatitis C; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Interferons; Liver Cirrhosis; Liver Failure; Liver Neoplasms; Multicenter Studies as Topic; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin	2006
Advances in the treatment of hepatitis C. Advances in internal medicine, 2000, Volume: 45 Topics: Antiviral Agents; Biopsy; Clinical Protocols; Disease Progression; Drug Therapy, Combination; Hepatitis C; Hepatitis C, Chronic; Humans; Interferon Type I; Liver Cirrhosis; Liver Failure; Ribavirin	2000
Hepatitis C virus in the transplant setting. Antiviral therapy, 1998, Volume: 3, Issue:Suppl 3 Topics: Antiviral Agents; Combined Modality Therapy; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Immunosuppression Therapy; Interferons; Liver Failure; Liver Transplantation; Recurrence; Ribavirin; RNA, Viral; Survival Rate; Time Factors; Tissue Donors	1998

Trials

5 trial(s) available for ribavirin and Liver Failure

Article	Year
Multicenter experience using telaprevir or boceprevir with peginterferon and ribavirin to treat hepatitis C genotype 1 after liver transplantation. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2013, Volume: 19, Issue:7 Topics: Aged; Antiviral Agents; Biopsy; Drug Therapy, Combination; Female; Genotype; Hepatitis C; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Interferon-alpha; Liver Failure; Liver Transplantation; Male; Middle Aged; Oligopeptides; Polyethylene Glycols; Proline; Recombinant Proteins; Ribavirin; RNA, Viral; Treatment Outcome	2013
Effect of HCV RNA suppression during peginterferon alfa-2a maintenance therapy on clinical outcomes in the HALT-C trial. Gastroenterology, 2009, Volume: 137, Issue:6 Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Disease Progression; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Kaplan-Meier Estimate; Liver Cirrhosis; Liver Failure; Liver Neoplasms; Male; Middle Aged; Polyethylene Glycols; Proportional Hazards Models; Prospective Studies; Recombinant Proteins; Ribavirin; RNA, Viral; Time Factors; Treatment Failure; Viral Load	2009
Risk factors for hepatic decompensation in patients with HIV/HCV coinfection and liver cirrhosis during interferon-based therapy. AIDS (London, England), 2004, Sep-03, Volume: 18, Issue:13 Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis C, Chronic; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Liver Failure; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Risk Factors	2004
Spontaneous hepatic decompensation in patients coinfected with HIV and hepatitis C virus during interferon-ribavirin combination treatment. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Dec-15, Volume: 41, Issue:12 Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Liver Failure; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin	2005
Interferon Alfa-2A and ribavirin therapy for hepatitis C recurrence after liver transplantation. Transplantation proceedings, 2000, Volume: 32, Issue:7 Topics: Adult; Aged; Antiviral Agents; Cause of Death; Drug Monitoring; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Liver Failure; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Recombinant Proteins; Recurrence; Ribavirin; Survival Rate; Time Factors; Treatment Outcome	2000

Other Studies

30 other study(ies) available for ribavirin and Liver Failure

Article	Year
Mechanisms of CD8+ T-cell failure in chronic hepatitis E virus infection. Journal of hepatology, 2022, Volume: 77, Issue:4 Topics: CD8-Positive T-Lymphocytes; Epitopes, T-Lymphocyte; Hepatitis E; Hepatitis E virus; Humans; Interferon-gamma; Liver Cirrhosis; Liver Failure; Ribavirin	2022
Treatment of Hepatitis E. Advances in experimental medicine and biology, 2023, Volume: 1417 Topics: Female; Hepatitis E; Humans; Liver Failure; Liver Transplantation; Pregnancy; Ribavirin	2023
Variable Outcomes of Hepatitis E Infections in Patients with Hemato-Oncologic Diseases. Oncology research and treatment, 2023, Volume: 46, Issue:7-8 Topics: Antiviral Agents; Hepatitis E; Hepatitis E virus; Humans; Liver Failure; Retrospective Studies; Ribavirin	2023
[Intrahepatic and extrahepatic clinical manifestations and treatment progress for hepatitis type E]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2023, May-20, Volume: 31, Issue:5 Topics: Antiviral Agents; Hepatitis E virus; Hepatitis, Chronic; Humans; Liver Diseases; Liver Failure; Ribavirin	2023
[Progress of antiviral therapy for hepatitis C virus-related decompensated cirrhosis]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2019, Dec-20, Volume: 27, Issue:12 Topics: Antiviral Agents; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Liver Failure; Ribavirin; Sofosbuvir; Treatment Outcome	2019
Successful treatment with sofosbuvir and daclatasvir plus ribavirin in acute hepatitis C-infected patient with hepatic decompensation. Journal of the Chinese Medical Association : JCMA, 2019, Volume: 82, Issue:7 Topics: Acute Disease; Aged; Antiviral Agents; Carbamates; Drug Therapy, Combination; Hepatitis C; Humans; Imidazoles; Liver Failure; Male; Pyrrolidines; Ribavirin; RNA, Viral; Sofosbuvir; Sustained Virologic Response; Valine	2019
European mitochondrial haplogroups predict liver-related outcomes in patients coinfected with HIV and HCV: a retrospective study. Journal of translational medicine, 2019, 07-26, Volume: 17, Issue:1 Topics: Adult; Antiviral Agents; Biopsy; Carcinoma, Hepatocellular; Coinfection; Disease Progression; DNA, Mitochondrial; Europe; Female; Genotype; Haplotypes; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Interferons; Liver; Liver Failure; Liver Neoplasms; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; Ribavirin; Risk	2019
Benefits from sustained virologic response to pegylated interferon plus ribavirin in HIV/hepatitis C virus-coinfected patients with compensated cirrhosis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2013, Volume: 56, Issue:11 Topics: Adult; Antiviral Agents; Female; Hepacivirus; Hepatitis C; HIV Infections; Humans; Interferon-alpha; Kaplan-Meier Estimate; Liver Cirrhosis; Liver Failure; Male; Middle Aged; Multivariate Analysis; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin	2013
Results of single-center screening for chronic hepatitis E in children after liver transplantation and report on successful treatment with ribavirin. Pediatric transplantation, 2013, Volume: 17, Issue:4 Topics: Adolescent; Antibodies, Viral; Antiviral Agents; Child; Child, Preschool; Cohort Studies; Female; Hepatitis; Hepatitis E; Humans; Immunoglobulin G; Immunosuppressive Agents; Infant; Liver Failure; Liver Transplantation; Male; Polymerase Chain Reaction; Postoperative Complications; Retrospective Studies; Ribavirin; RNA, Viral	2013
Chronic rejection associated with antiviral therapy for recurrent hepatitis C after living-donor liver transplantation. Transplantation, 2014, Feb-15, Volume: 97, Issue:3 Topics: Adult; Aged; Antiviral Agents; Female; Fibrosis; Graft Rejection; Hepatitis C; Humans; Immunosuppressive Agents; Interferon-alpha; Interferons; Liver Failure; Liver Transplantation; Living Donors; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Recurrence; Retrospective Studies; Ribavirin; Risk Factors; Time Factors; Treatment Outcome	2014
Pregnant woman saved with liver transplantation from acute liver failure due to hepatitis E virus. Transplant international : official journal of the European Society for Organ Transplantation, 2014, Volume: 27, Issue:9 Topics: Acetylcysteine; Acute Disease; Adult; Antibodies, Viral; Antiviral Agents; Asia, Southeastern; Cesarean Section; Combined Modality Therapy; Emergencies; Female; Hepatitis E; Hepatitis E virus; Humans; Immunity, Maternally-Acquired; Immunoglobulin G; Immunoglobulin M; Infant, Newborn; Liver Failure; Liver Transplantation; Plasma; Pregnancy; Pregnancy Complications, Infectious; Ribavirin	2014
Haemophilia-related outcome after liver transplantation and treatment with sofosbuvir/ribavirin in a HCV-HIV coinfected man with liver failure and hepatocellular carcinoma. Haemophilia : the official journal of the World Federation of Hemophilia, 2015, Volume: 21, Issue:2 Topics: Adult; Antiretroviral Therapy, Highly Active; Antiviral Agents; Carcinoma, Hepatocellular; Coinfection; Hemophilia A; Hepatitis C; HIV Infections; Humans; Liver Failure; Liver Transplantation; Male; Ribavirin; Sofosbuvir; Treatment Outcome; Uridine Monophosphate	2015
Association Between Severe Portal Hypertension and Risk of Liver Decompensation in Patients With Hepatitis C, Regardless of Response to Antiviral Therapy. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2015, Volume: 13, Issue:10 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Female; Hepatitis C, Chronic; Humans; Hypertension, Portal; Interferon-alpha; Liver Failure; Liver Neoplasms; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Risk Assessment; Spain; Survival Analysis; Treatment Outcome; Viral Load	2015
Hepatic decompensation/serious adverse events in post-liver transplantation recipients on sofosbuvir for recurrent hepatitis C virus. World journal of gastroenterology, 2016, Mar-07, Volume: 22, Issue:9 Topics: Adult; Aged; Anemia; Antiviral Agents; Drug Therapy, Combination; End Stage Liver Disease; Female; Hepacivirus; Hepatitis C; Humans; Kaplan-Meier Estimate; Liver Failure; Liver Transplantation; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Recurrence; Ribavirin; Risk Factors; Sofosbuvir; Time Factors; Treatment Outcome; Virus Activation	2016
Nursing Problems in Care of a Patient with Very Early HCV Infection Recurrence After Liver Transplantation: A Case Report. Annals of transplantation, 2016, Jun-30, Volume: 21 Topics: Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C; Humans; Interferons; Liver Failure; Liver Transplantation; Oligopeptides; Postoperative Complications; Recurrence; Reoperation; Ribavirin; Sofosbuvir; Treatment Outcome; Young Adult	2016
Daclatasvir plus sofosbuvir, with or without ribavirin, achieved high sustained virological response rates in patients with HCV infection and advanced liver disease in a real-world cohort. Gut, 2016, Volume: 65, Issue:11 Topics: Adult; Aged; Antiviral Agents; Carbamates; Cohort Studies; Compassionate Use Trials; Drug Monitoring; Drug Therapy, Combination; Europe; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Liver Failure; Male; Middle Aged; Pyrrolidines; Ribavirin; Severity of Illness Index; Sofosbuvir; Treatment Outcome; Valine	2016
Antiviral treatment of recurrent hepatitis C after liver transplantation: predictors of response and long-term outcome. Transplantation, 2009, Nov-27, Volume: 88, Issue:10 Topics: Adrenal Cortex Hormones; Adult; Aged; Antiviral Agents; Drug Tolerance; Female; Follow-Up Studies; Genotype; Hepatitis C; Humans; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Liver Failure; Liver Transplantation; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Recurrence; Retrospective Studies; Ribavirin; Survival Rate; Tacrolimus; Time Factors; Tissue Donors; Treatment Outcome	2009
Treatment of hepatitis C-virus-reinfection after liver transplant with silibinin in nonresponders to pegylated interferon-based therapy. Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, 2011, Volume: 9, Issue:1 Topics: Adult; Aged; Alanine Transaminase; Antiviral Agents; Aspartate Aminotransferases; Biomarkers; Drug Administration Schedule; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C; Humans; Infusions, Intravenous; Interferon alpha-2; Interferon-alpha; Liver Failure; Liver Transplantation; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Recurrence; Ribavirin; RNA, Viral; Silybin; Silymarin; Time Factors; Treatment Failure; Viral Load	2011
Case 10-2011: Fever, confusion, and liver failure. The New England journal of medicine, 2011, 07-14, Volume: 365, Issue:2 Topics: Antiviral Agents; Female; Hepatitis C, Chronic; Hepatitis, Autoimmune; Humans; Interferon-alpha; Liver Failure; Lymphohistiocytosis, Hemophagocytic; Middle Aged; Ribavirin	2011
Case report of successful peginterferon, ribavirin, and daclatasvir therapy for recurrent cholestatic hepatitis C after liver retransplantation. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2012, Volume: 18, Issue:9 Topics: Alkaline Phosphatase; Antiviral Agents; Bilirubin; Biomarkers; Carbamates; Cholestasis; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C; Humans; Imidazoles; Immunosuppressive Agents; Interferon-alpha; Liver Failure; Liver Transplantation; Middle Aged; Polyethylene Glycols; Pyrrolidines; Recombinant Proteins; Recurrence; Reoperation; Ribavirin; RNA, Viral; Time Factors; Treatment Outcome; Valine; Viral Load	2012
Liver-kidney recipients with chronic viral hepatitis C treated with interferon-alpha. Transplant international : official journal of the European Society for Organ Transplantation, 2012, Volume: 25, Issue:9 Topics: Acute Disease; Adult; Aged; Biopsy; Female; Graft Rejection; Hepatitis C; Humans; Immunosuppressive Agents; Interferon-alpha; Kidney Transplantation; Liver; Liver Failure; Liver Transplantation; Male; Middle Aged; Recurrence; Renal Insufficiency; Retrospective Studies; Ribavirin; Steroids; Transaminases; Treatment Outcome	2012
Is treatment failure for hepatitis C virus infection in HIV-positive drug users associated with a shift in HCV genotypes? Journal of acquired immune deficiency syndromes (1999), 2003, Apr-01, Volume: 32, Issue:4 Topics: Antiviral Agents; Disease Progression; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C; HIV Seropositivity; Humans; Interferons; Liver Failure; Liver Function Tests; Ribavirin; Risk-Taking; Substance Abuse, Intravenous; Treatment Failure	2003
The long-term effects of immune suppression on liver transplant recipients with recurrent hepatitis C viral infection. Transplantation proceedings, 2004, Volume: 36, Issue:10 Topics: Antiviral Agents; Biopsy; Hepatitis C; Humans; Immunosuppression Therapy; Interferon alpha-2; Interferon-alpha; Liver Failure; Liver Transplantation; Middle Aged; Recombinant Proteins; Recurrence; Retrospective Studies; Ribavirin; Survival Analysis; Treatment Outcome	2004
[Complications in a patient with liver cirrhosis and HCV coinfection during treatment with peginterferon and ribavirin]. Przeglad epidemiologiczny, 2005, Volume: 59, Issue:2 Topics: Adolescent; Antiviral Agents; Biliary Atresia; Child; Female; Hepatitis C, Chronic; Humans; Hypertension, Portal; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Liver Failure; Liver Transplantation; Polyethylene Glycols; Portasystemic Shunt, Transjugular Intrahepatic; Recombinant Proteins; Ribavirin; Treatment Outcome	2005
Vitiligo improvement in a hepatitis C patient after treatment with PEG-interferon alpha-2a and ribavirin: a case report. Digestive diseases and sciences, 2007, Volume: 52, Issue:12 Topics: Antiviral Agents; Drug Carriers; Drug Therapy, Combination; Follow-Up Studies; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Failure; Liver Transplantation; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Viral Load; Vitiligo	2007
Summaries for patients. Sustained virologic response in hepatitis C. Annals of internal medicine, 2007, Nov-20, Volume: 147, Issue:10 Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Liver Failure; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Recombinant Proteins; Retrospective Studies; Ribavirin; RNA, Viral; Treatment Outcome	2007
Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis. Annals of internal medicine, 2007, Nov-20, Volume: 147, Issue:10 Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Liver Failure; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Recombinant Proteins; Retrospective Studies; Ribavirin; RNA, Viral; Treatment Outcome	2007
Recurrent hepatitis C after liver transplantation: on-treatment prediction of response to peginterferon/ribavirin therapy. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2008, Volume: 14, Issue:1 Topics: Antiviral Agents; Biopsy; Drug Carriers; Drug Therapy, Combination; Female; Follow-Up Studies; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Failure; Liver Transplantation; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Recurrence; Retrospective Studies; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin; RNA, Viral; Treatment Outcome	2008
Subfulminant syncytial giant cell hepatitis: recurrence after liver transplantation treated with ribavirin. Journal of hepatology, 1997, Volume: 26, Issue:3 Topics: Acute Disease; Adult; Antiviral Agents; Biopsy; Follow-Up Studies; Giant Cells; Hepatitis; Humans; Liver Failure; Liver Transplantation; Male; Recurrence; Ribavirin	1997
Making end points meet. Gastroenterology, 1999, Volume: 116, Issue:5 Topics: Biomarkers; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Failure; Prospective Studies; Recombinant Proteins; Ribavirin; RNA, Viral; Survival Rate; Transaminases; Treatment Outcome; Viral Load	1999